| 产品名称： | pRRB20IF-23 SCC2128 |
|---|---|
| 商品货号： | TS136424 |
| Designations： | pRRB20IF-23 SCC2128 |
| Species： | Homo sapiens, human |
| Depositors： | Schering Corp. |
| Applications： | produces protein interferon, type 1, cluster interferon alpha gene family (leukocyte), interferon, alpha (leukocyte), interferon, type 1, cluster |
| Insert： | DNA: cDNA Insert lengths(kb): 1.899999976158142 Gene product: interferon, alpha 2 IFNA2 Target Gene: interferon, type 1, cluster |
| Insert Size (kb)： | 1.900 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Shipping Information： | Distributed: freeze-dried |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--7.2; EcoRI/BamHI--4.3, 3.0; EcoRI/PstI--5.9, 1.4; BglII--7.0, 0.2; EcoRI/BglII--4.0, 3.1, 0.2. Expresses IFNA2 using the encoded T7 RNA polymerase. The plasmid consists of the following elements with their directions of transcription: T7 gene 10 promoter > - IFNA2 > - < T7 gene 1.1 promoter - < T7 gene 1D - < lac po - < pMB1 ori - < ampR. |
| References： | Reim RL, et al. Expression systems utilizing bacteriophage T7 promoters, gene sequences, and T7 RNA polymerase. US Patent 5,122,457 dated Jun 16 1992 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | pRRB20IF-23 SCC2128 |
|---|---|
| 商品货号： | TS136424 |
| Designations： | pRRB20IF-23 SCC2128 |
| Species： | Homo sapiens, human |
| Depositors： | Schering Corp. |
| Applications： | produces protein interferon, type 1, cluster interferon alpha gene family (leukocyte), interferon, alpha (leukocyte), interferon, type 1, cluster |
| Insert： | DNA: cDNA Insert lengths(kb): 1.899999976158142 Gene product: interferon, alpha 2 IFNA2 Target Gene: interferon, type 1, cluster |
| Insert Size (kb)： | 1.900 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Shipping Information： | Distributed: freeze-dried |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--7.2; EcoRI/BamHI--4.3, 3.0; EcoRI/PstI--5.9, 1.4; BglII--7.0, 0.2; EcoRI/BglII--4.0, 3.1, 0.2. Expresses IFNA2 using the encoded T7 RNA polymerase. The plasmid consists of the following elements with their directions of transcription: T7 gene 10 promoter > - IFNA2 > - < T7 gene 1.1 promoter - < T7 gene 1D - < lac po - < pMB1 ori - < ampR. |
| References： | Reim RL, et al. Expression systems utilizing bacteriophage T7 promoters, gene sequences, and T7 RNA polymerase. US Patent 5,122,457 dated Jun 16 1992 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
